This kit pairs VIP, a neuropeptide studied for VPAC receptor signaling in neuroimmune research, with ARA-290, an erythropoietin-derived peptide studied for tissue-protective innate repair receptor signaling, and Thymosin Alpha-1, studied for immune-cell modulation, three distinct protective-signaling systems in one panel.
HPLC certified
Independent analysis
Highest standard
Full traceability
Vascular, Immune & Protection combines VIP 5mg, ARA-290 16mg, and Thymosin Alpha-1 10mg, three peptides addressing separate layers of protective biological signaling.
VIP is studied for VPAC receptor signaling in neuroimmune research. ARA-290 is studied for innate repair receptor signaling in tissue-protective research, and Thymosin Alpha-1 is studied for T-cell modulation at the immune-cell level.
All three vials ship individually labeled and independently HPLC-verified before batch release. This product is intended strictly for laboratory research use only and is not approved for human consumption.
The Vascular, Immune & Protection kit pairs VIP, a neuropeptide studied for VPAC receptor signaling in neuroimmune research, with ARA-290, an erythropoietin-derived peptide studied for tissue-protective innate repair receptor signaling, and Thymosin Alpha-1, studied for immune-cell modulation, three distinct protective-signaling systems in one panel.
This panel groups three peptides that each address a different layer of protective biological signaling, neuroimmune receptor activity, tissue-protective repair signaling, and immune-cell modulation. None of the three overlap directly, which is the reason they were selected together rather than any two of them being sufficient on their own.
| Vial | Peptide | Strength | Research Focus |
|---|---|---|---|
| Vial 1 | VIP | 5mg | VPAC receptor signaling in neuroimmune and circadian-biology research. |
| Vial 2 | ARA-290 | 16mg | Innate repair receptor signaling associated with tissue-protective pathways. |
| Vial 3 | Thymosin Alpha-1 | 10mg | T-cell modulation and innate/adaptive immune signaling research. |
VIP (Vasoactive Intestinal Peptide) is a naturally occurring neuropeptide with broad receptor distribution, studied for VPAC receptor signaling relevant to neuroimmune and circadian-biology research. Its dual relevance to both neural and immune signaling makes it a bridging compound between the neuropeptide research category and the tissue-protective research category this kit otherwise focuses on. VPAC receptors are distributed across multiple tissue types, which is part of why VIP research spans such a broad range of downstream applications compared to more narrowly tissue-specific peptides.
ARA-290 is an erythropoietin-derived peptide, studied for innate repair receptor signaling associated with tissue-protective pathways, a mechanism distinct from VIP's neuroimmune receptor focus. Being derived from erythropoietin connects ARA-290's research lineage to a well-characterized parent hormone, while its own research focus narrows specifically to the tissue-protective, non-hematopoietic signaling pathway rather than erythropoietin's classical blood-cell-production role. This distinction, tissue-protective signaling separated from erythropoietin's classical function, is itself an active area of comparative research interest.
Unlike the Repair Trio or Advanced Repair & Immune kits, which focus on structural tissue repair, angiogenesis, cell migration, matrix remodeling, this kit focuses on the protective and immune-regulatory side of biology rather than direct structural repair. Researchers studying protective signaling pathways as their own research question, rather than as a component of wound-healing research specifically, are the better fit for this kit.
Thymosin Alpha-1 also appears in the Gut & Mucosal Panel kit, but in that context it is paired with gastrointestinal-specific compounds, BPC-157 and KPV, rather than the broader neuroimmune and tissue-protective peptides in this kit. Both kits use Thymosin Alpha-1 for the same underlying T-cell modulation research, the surrounding compounds simply narrow the applied research context differently, gut-tissue immunity in one case, broader protective-signaling research in this one.
For structural tissue-repair research instead, see Repair Trio. For gastrointestinal-specific immune and repair research that also includes Thymosin Alpha-1, see Gut & Mucosal Panel. Browse the full Peptide Bundles collection for the complete lineup.
Each of the three vials ships individually labeled with compound name, strength, and batch lot number, none are pre-mixed. Every vial is independently verified through HPLC before batch release.
This product is intended strictly for laboratory research use only. It is not approved for human consumption, therapeutic application, or diagnostic purposes.
Telomerase enzyme explained: how TERT and TERC maintain telomeres, why it matters in aging and cancer research, plus RUO peptide sourcing. Read the guide.
KLOW peptide research blend is drawing attention across California's research community. Discover its composition, COA basics, and current evidence limits.
Learn what a peptide bond is, how it forms through dehydration synthesis, and why its structure matters for research peptides. Read the full guide now.
(faqs)
